The combination of aptamers with novel nanomaterials, including nanomaterial-based
aptamer bioconjugates has attracted considerable interest and has led to a wide variety of …

In recent years, nanomaterials have captured the attention of scientists from a wide spectrum
of domains. With their unique properties, nanomaterials offer great promise for numerous …

A wide variety of nanomaterials have emerged in recent years with advantageous properties
for a plethora of therapeutic and diagnostic applications. Such applications include drug …

Aptamers represent a class of single‐stranded DNA or RNA oligonucleotides that play
important roles in biosensing and biomedical applications. However, aptamers can gain …

Aptamers are composed of short RNA or single‐stranded DNA sequences that, when folded
into their unique 3D conformation, can bind to their targets with high specificity and affinity …

The active targeting of drugs in a cell-, tissue-or disease-specific manner represents a
potentially powerful technology with widespread applications in medicine, including the …

Recent progress in an emerging area of designing aptamer and nanomaterial conjugates as
molecular diagnostic and drug delivery agents in biomedical applications is summarized …

Based on their unique advantages, increasing interest has been shown in the use of
aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy …

Aptamers are versatile nucleic acid-based macromolecules characterized by their high
affinity and specificity to a specific target. Taking advantage of such binding properties …

Nucleic acid ligands, also known as aptamers, are a class of macromolecules that are being
used in several novel nanobiomedical applications. Aptamers are characterized by high …